Further, we reported that CD4+ T cells expressing CD39 or CD73 were present in tumor tissues (HNSCC), and that at least some CD4+CD25+ Treg infiltrating these tumors co-expressed the two markers in situ (13). Here, NT5E is linked to neoplasm.